Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,700
Closed -$2.98M 1716
2025
Q4
$2.98M Hold
37,700
0.01% 717
2025
Q3
$3.11M Sell
37,700
-8,000
-18% -$630K 0.01% 625
2025
Q2
$3.68M Buy
45,700
+8,000
+21% +$617K 0.03% 530
2025
Q1
$3.03M Buy
37,700
+21,300
+130% +$1.77M 0.03% 555
2024
Q4
$1.34M Sell
16,400
-21,500
-57% -$1.79M 0.01% 686
2024
Q3
$3.13M Hold
37,900
0.02% 483
2024
Q2
$2.66M Hold
37,900
0.02% 480
2024
Q1
$2.81M Buy
+37,900
New +$2.64M 0.03% 472

Other funds holding MET

LMR Partners's MET Position: Q1 2026 in Review

LMR Partners increased its MetLife (MET) stake by 927% in Q1 2026, buying an estimated $351K and bringing the position to 5,199 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #1117.

LMR Partners first reported a position in MET in Q3 2015 and has held it in 15 quarters since. The position peaked at $2.79M in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • LMR Partners held 5,199 shares of MetLife worth $368K as of Q1 2026.
  • LMR Partners bought 4,693 MetLife shares in Q1 2026, an estimated $351K.
  • MetLife made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1117 holding.
  • LMR Partners first reported a position in MetLife in Q3 2015 and has held it in 15 quarters since.
  • LMR Partners's MetLife position peaked at $2.79M in Q4 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.